Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis

International Journal of Clinical Oncology

Volumn 19, Issue 2, 2014, Pages 260-265

  Watanabe, Naohiro ^a   Taniguchi, Hiroyuki ^a   Kondoh, Yasuhiro ^a   Kimura, Tomoki ^a   Kataoka, Kensuke ^a   Nishiyama, Osamu ^b   Kondo, Masashi ^c   Hasegawa, Yoshinori ^c  

^a TOSEI GENERAL HOSPITAL   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Idiopathic pulmonary fibrosis; Small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; DISTANT METASTASIS; DRUG EFFICACY; FEBRILE NEUTROPENIA; FIBROSING ALVEOLITIS; GENERAL CONDITION DETERIORATION; HUMAN; LEUKOPENIA; LUNG SMALL CELL CANCER; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SIDE EFFECT; SYSTEMIC THERAPY; THROMBOCYTOPENIA; TREATMENT RESPONSE; COMPLICATION; FEMALE; LUNG NEOPLASMS; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SMALL CELL LUNG CARCINOMA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA;

EID: 84899988574     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-013-0554-5     Document Type: Article

References (27)

1. Hubbard R, Venn A, Lewis S et al (2000) Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161:5-8 (Pubitemid 30055895)
2. Harris JM, Johnston ID, Rudd R et al (2010) Cryptogenic fibrosing alveolitis and lung cancer: the BTS study. Thorax 65:70-76
3. Le Jeune I, Gribbin J, West J et al (2007) The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 101:2534-2540 (Pubitemid 47618391)
4. Turner-Warwick M, Lebowitz M, Burrows B et al (1980) Cryptogenic fibrosing alveolitis and lung cancer. Thorax 35:496-499 (Pubitemid 10039553)
5. Park J, Kim DS, Shim TS et al (2001) Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 17:1216-1219 (Pubitemid 32717481)
6. Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788-824
7. Vancheri C, Failla M, Crimi N et al (2010) Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 35:496-504
8. Königshoff M (2011) Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity. Respiration 81:353-358
9. Minegishi Y, Kuribayashi H, Kitamura K et al (2011) The feasibility study of carboplatin plus etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias. J Thorac Oncol 6:801-807
10. Kenmotsu H, Naito T, Kimura M et al (2011) The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol 6:1242-1246
11. Togashi Y, Masago K, Handa T et al (2012) Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer. Clin Lung Cancer 13:304-311
12. Watanabe N, Taniguchi H, Kondoh Y et al (2012) Efficacy of chemotherapy for advanced non-small cell lung cancer with idiopathic pulmonary fibrosis. Respiration. doi:10.1159/000342046
13. Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319-338 (Pubitemid 41079078)
14. Macintyre N, Crapo RO, Viegi G et al (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26:720-735 (Pubitemid 41448672)
15. Johkoh T, Müller NL, Cartier Y et al (1999) Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 211:555-560 (Pubitemid 29206830)
16. Nishimura K, Kitaichi M, Izumi T et al (1992) Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 182:337-342
17. Song JW, Hong SB, Lim CM et al (2011) Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 37:356-363
18. American Thoracic Society; European Respiratory Society (2002) American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277-304
19. Schmittel A, Sebastian M, Fischer von Weikersthal L et al (2011) A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer. Ann Oncol 22:1798-1804
20. Socinski MA, Smit EF, Lorigan P et al (2009) Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer. J Clin Oncol 27:4787-4792
21. Okamoto H, Watanabe K, Kunikane H et al (2007) Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Br J Cancer 97:162-169 (Pubitemid 47057464)
22. Kokron O, Micksche M, Titscher R et al (1982) Ifosfamide versus ifosfamide + CCNU in the treatment of inoperable small cell carcinoma of the lung. A clinical study. Onkologie 5:56-59 (Pubitemid 12046491)
23. Kudoh S, Kato H, Nishiwaki Y et al (2008) Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am J Respir Crit Care Med 177:1348-1357 (Pubitemid 351860912)
24. Kondoh Y, Taniguchi H, Katsuta T et al (2010) Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 27:103-110
25. Suda T, Kaida Y, Nakamura Y et al (2009) Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 103:846-853
26. Park IN, Kim DS, Shim TS et al (2007) Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132:214-220 (Pubitemid 47068224)
27. Azuma A, Hagiwara A, Kudoh S (2008) Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients. Am J Respir Crit Care Med 177:1397-1398 (Pubitemid 351860920)